Hello Nature readers, would you like to get this Briefing in your inbox free every day? Sign up here

People wait to be seen at a clinic in Johannesburg, South Africa, that offers drugs to treat or prevent HIV infection.Credit: Foto24/Gallo Images/Getty
Promising HIV-prevention drug has a flaw
One year ago, an injectable drug was lauded for preventing HIV — but it looks less perfect today, in light of a new analysis. Researchers revisited blood samples collected in a 4,570-person clinical trial of the drug, called cabotegravir. They found that four people who contracted HIV, despite having received injections of the medication, had been infected for more than a month before ordinary HIV tests detected the virus. The team thinks that cabotegravir suppressed the virus enough to prevent the HIV tests from detecting it during early stages of infection. During this time, the virus developed resistance to cabotegravir. “The take-home message here is that we need better diagnostics, and we need to be ready to get people into suppressive treatment as soon as you diagnose the infection,” says HIV-prevention researcher Raphael Landovitz.
Plan now for COVID-19 vaccine surpluses
Countries such as Canada, the United States and the United Kingdom have secured enough doses of COVID-19 vaccines to protect their populations many times over. Though many are still struggling to roll the jabs out, eventually they will have hundreds of millions of surplus doses. Global health leaders say the time is now to plan how to share that bounty. “There are a whole set of issues that one needs to work through with regulators, and indemnification and liability on the contracts between manufacturers and countries that say how the doses can be used,” explains Nicole Lurie at the Coalition for Epidemic Preparedness Innovations, which helps to run the COVID-19 Vaccines Global Access (COVAX) programme, an international coalition aiming to fairly distribute vaccines. “It’s not as simple as just saying to COVAX, here are some doses.”
A mind-reading headband for horses
A wearable electroencephalogram (EEG) headband for horses could give us insight into how the animals feel. Researchers developed the device to measure the mental states of horses housed in typical stables compared with those who spend most of their time outside. Of 18 horses tested, the confined animals showed more right-hemisphere gamma brain waves, which can be a sign of anxiety, distraction or depression in people. Horses in open fields had more left-hemisphere theta waves, which are generally a sign of a calm and attentive mind in people. The technique could offer a glimpse into the mental states of other animals, too. But scientists caution that brain-wave interpretations for humans don’t necessarily translate to other species.
Reference: Applied Animal Behaviour Science paper
Features & opinion
Fresh takes on the CRISPR revolution
In two new books, biographer Walter Isaacson and bioethicist Henry Greely grapple with the thorny ethical questions and bitter scientific competition behind genome editing. “Reading them together gives insight into what the CRISPR story means — for knowledge, for society and for research as an endeavour,” writes reviewer Jackie Leach Scully.
What I learnt from 700 e-mail applications
Mechanical engineer Ronith Stanly wrote more than 700 e-mail applications for research opportunities following his undergraduate degree — and was unsuccessful almost as many times. “But the rejections taught me valuable, career-defining lessons,” writes Stanly, who is now starting a PhD programme in Stockholm. He shares how he came to stand out from the crowd.
Why nuclear energy’s role is shrinking
Anniversaries of the Fukushima and Chernobyl disasters highlight the challenges of relying on nuclear power to cut net carbon emissions to zero. “Clearly, nuclear energy will be with us for some time,” argues a Nature editorial. “But it is not proving to be the solution it was once seen as for decarbonizing the world’s energy market.” Instead, the focus must be on renewable energies that are available to all nations and don’t involve national or international defence apparatus.